Search Within

Jianda Yuan

  1. "Surgery"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
Groups
  1. Department of Medicine (20)
  2. GSK Faculty (20)
  3. Melanoma and Immunotherapeutics Service (20)
  4. Solid Tumor Oncology Division (20)
  5. Surgery (20)
  6. Department of Pathology and Laboratory Medicine (17)

More Groups

People
  1. Jedd Wolchok (20)
  2. Clifford Hudis (11)
  3. Edi Brogi (11)
  4. Heather Mcarthur (11)
  5. Larry Norton (11)
  6. Monica Morrow (11)

More People

Years
  1. 2018 (1)
  2. 2016 (2)
  3. 2015 (1)
  4. 2014 (5)
  5. 2013 (6)
  6. 2012 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Immunology Research (3)
  3. Cancer Research (3)
  4. Journal for ImmunoTherapy of Cancer (2)
  5. Nature Medicine (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (7)
  3. Biomed Central Ltd (2)
  4. Nature Publishing Group (2)
  5. Academy of Cancer Immunology (1)
  6. Springer (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling
    Journal Article

    McArthur, H. L.; Diab, A.; Page, D. B.; Yuan, J.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Durack, J. C.; Maybody, M.; Sung, J.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy
    Journal Article

    Page, D. B.; Yuan, J.; Redmond, D.; Wen, Y. H.; Durack, J. C.; Emerson, R.; Solomon, S.; Dong, Z.; Wong, P.; Comstock, C.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilinournab (ipi)
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J. D.; Dong, Z. W.; Emerson, R.; Robins, H.; Redmond, D.; Zhao, C. J.; Mu, Z. Y.; Wong, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Mcarthur, H. L.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC)
    Meeting Abstract

    Page, D. B.; Yuan, J. D.; Ginsberg, A.; Dong, Z.; Wong, P.; Emerson, R.; Sung, J. S.; Comstock, C.; Solomon, S. B.; Sacchini, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor
    Journal Article

    Callahan, M. K.; Masters, G.; Pratilas, C. A.; Ariyan, C.; Katz, J.; Kitano, S.; Russell, V.; Gordon, R. A.; Vyas, S.; Yuan, J. D.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save